Superbugs spur FDA, drug firms to action



 
Superbugs spur FDA, drug firms to action


Baxter gets OK to sell MRSA-blocking device; agency speeds reviews



As the bacterium MRSA becomes more widespread, the federal government and the drug and medical-device industries are recognizing the need to speed up the fight to combat superbugs, in what could be a multibillion-dollar market for tests, products and pharmaceuticals.

read more...

News entry number 3180 added on Nov 11, 2007 in the Business News category.

Comenteaza  

Rating: 0.00 (din 5)
Voturi 0

Adauga Rating


Other News in the Business News category
Categorie:

Categorie:

Categorie:

Categorie:

Categorie:


Related Links



News Categories


Top 10 News

Statistics

News:
News Categories:
News Read:
5052
8
617